Bigfoot Biomedical

About Bigfoot Biomedical

Bigfoot Biomedical is a pioneering company in the diabetes care market, focusing on innovative solutions for individuals requiring insulin. The company operates in the healthcare technology sector, specifically targeting people with Type 1 and Type 2 diabetes who need insulin therapy. Bigfoot Biomedical's primary offering is a comprehensive digital drug delivery platform that simplifies and optimizes insulin management. This platform is designed to be user-friendly and is experienced as a service, meaning it provides ongoing support and monitoring rather than just a one-time product.

Bigfoot's business model revolves around partnering with healthcare providers to deliver these solutions. By integrating their technology with healthcare services, they enable remote physiologic monitoring (RPM), which allows healthcare professionals to track patients' health data remotely. This approach not only improves patient outcomes but also reduces the burden on healthcare providers by making diabetes management more efficient and accessible.

The company generates revenue through a subscription-based model, where clients—primarily healthcare providers and patients—pay for the continuous use of Bigfoot's digital platform and associated services. This model ensures a steady income stream while providing ongoing value to users.

Bigfoot Biomedical's mission is to change the paradigm of diabetes care by focusing on simplicity, ease of use, and broadening access to effective insulin management solutions. Their goal is to reduce the daily burden of diabetes for a large population, improve health equity, and support healthcare providers in delivering optimal care.

The company is based in Silicon Valley and boasts a team of experts from various fields, including medical technology, enterprise software, and consumer technology. This diverse expertise allows Bigfoot to tackle the complex challenges of diabetes care with innovative and effective solutions.